Brochure: RP-HPLC columns for proteins and peptides
Posted: 11 February 2021 | Merck | No comments yet
The Discovery® BIO wide pore reversed-phase HPLC columns and capillaries provide sensitive, stable, efficient and reproducible separations.
In proteomics and biopharmaceutical research there is a need to obtain as much information as possible on very limited sample amounts. The Discovery® BIO columns address this challenge, satisfying the need for efficiency, selectivity, LC/MS sensitivity, stability, scalability and reproducibility. They offer three phase chemistries (C18, C8, C5), a low-bleed feature, inert surface chemistry, as well as microbore and capillary dimensions ideal for proteomics and LC/MS applications.
Related content from this organisation
- MSD set to acquire novel antibody for B-cell malignancies
- Novel immunotherapy combination approved for endometrial cancer
- Innovating small molecule injectables: market forecast to 2033
- Ophthalmology acquisition to advance tri-specific antibody
- Antibody-immunotherapy treatment shows benefit in serious endometrial cancer
Related topics
Analytical techniques, Biopharmaceuticals, Formulation, QA/QC, Regulation & Legislation, Research & Development (R&D)
